More on PLRZ
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.39 |
|
|||
| Open | $14.39 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $15.31 | ||||
| Day Low | $13.59 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 92,925 | ||||
- Form 6-K Polyrizon Ltd. For: Jul 13
- Core AI Holdings names Arie Goor as CFO, effective July 1
- Form 6-K Polyrizon Ltd. For: Jul 02
- Polyrizon completes biocompatibility tests for NASARIX nasal spray
- Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
- Form 6-K Polyrizon Ltd. For: Jun 29
- Polyrizon gets IRB approval for NASARIX allergy blocker trial
- Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial
- Form 6-K Polyrizon Ltd. For: Jun 17
- Polyrizon patent application for nasal drug delivery platform published in U.S.
Entities mentioned with PLRZ
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- F1 | View Related Stories »
- 13G | View Related Stories »
- IPO | View Related Stories »
- Show More...
